Regulatory Action Against Ranbaxy’s Paonta Sahib Plant in India
Information on Drugs Manufactured at the Dewas and Paonta Sahib Facilities of Ranbaxy Laboratories, Ltd.
February 25, 2009
- FDA AIP Letter to Ranbaxy Laboratories (updated 3/2/2009)
- FDA News: FDA Takes New Regulatory Action Against Ranbaxy's Paonta Sahib Plant in India
- Application Integrity Policy List
September 16, 2008
- FDA Press Release: FDA Issues Warning Letters to Ranbaxy Laboratories Ltd., and an Import Alert for Drugs from Two Ranbaxy Plants in India
List of Drugs Manufactured at the Dewas and Paonta Sahib Facilities of Ranbaxy Laboratories, Ltd.
- Questions and Answers
- Warning Letter Dewas, India
- Warning Letter Batamandi (Unit II), in Paonta Sahib, India